TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients

Anna A. Brożyna, Huazhang Guo, Sun Eun Yang, Lynn Cornelius, Gerald Linette, Michael Murphy, Christine Sheehan, Jeffrey Ross, Andrzej Slominski, J. Andrew Carlson

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences